The scientist first tested their theory on human lens cells. The studies showed that when lanosterol was applied to the cells, lens proteins stopped clumping and transparency increased. Next, they studied rabbits suffering from cataracts. After administering lanosterol for six days, 85% of the rabbits had a significant lessening of the severity of their cataracts. Cataracts in dogs were also investigated. Black Labrador Retrievers, Queensland Heelers and Miniature Pinschers, all dogs with significant naturally occurring cataracts, responded in similar fashion as the rabbits.
Although it’s not entirely clear how lanosterol is working, the researchers believe that the steroid prevents the proteins from building up. According to Tech Times , if the drops prove to also work on humans, they could offer a non-invasive treatment for individuals with mild to moderate cataracts and serve as a way to prevent the condition from ever returning. While cataract surgery is relatively easy and safe, the drops would serve as an easier alternative for the 50 million Americans estimated to be afflicted by the condition by the year 2050.